Geneos Wealth Management’s Ameriprise Financial AMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52K | Hold |
117
| – | – | ﹤0.01% | 1414 |
|
|
2025
Q4 | $57.4K | Sell |
117
-25
| -18% | -$11.9K | ﹤0.01% | 1343 |
|
|
2025
Q3 | $69.9K | Sell |
142
-305
| -68% | -$156K | ﹤0.01% | 1252 |
|
|
2025
Q2 | $239K | Sell |
447
-94
| -17% | -$46.4K | 0.01% | 931 |
|
|
2025
Q1 | $548K | Buy |
541
+193
| +55% | +$101K | 0.01% | 862 |
|
|
2024
Q4 | $185K | Sell |
348
-6
| -2% | -$3.2K | 0.01% | 870 |
|
|
2024
Q3 | $166K | Buy |
354
+257
| +265% | +$112K | 0.01% | 817 |
|
|
2024
Q2 | $41.4K | Sell |
97
-40
| -29% | -$17.1K | ﹤0.01% | 1130 |
|
|
2024
Q1 | $60.1K | Buy |
137
+50
| +57% | +$20K | ﹤0.01% | 1007 |
|
|
2023
Q4 | $33K | Buy |
87
+6
| +7% | +$2.06K | ﹤0.01% | 1197 |
|
|
2023
Q3 | $26.7K | Hold |
81
| – | – | ﹤0.01% | 1280 |
|
|
2023
Q2 | $26.9K | Hold |
81
| – | – | ﹤0.01% | 1275 |
|
|
2023
Q1 | $24.8K | Sell |
81
-221
| -73% | -$72.4K | ﹤0.01% | 1277 |
|
|
2022
Q4 | $94K | Buy |
302
+24
| +9% | +$7.32K | 0.01% | 844 |
|
|
2022
Q3 | $70K | Sell |
278
-446
| -62% | -$117K | ﹤0.01% | 916 |
|
|
2022
Q2 | $172K | Hold |
724
| – | – | 0.01% | 801 |
|
|
2022
Q1 | $217K | Sell |
724
-56
| -7% | -$16.9K | 0.01% | 771 |
|
|
2021
Q4 | $235K | Sell |
780
-9
| -1% | -$2.66K | 0.01% | 792 |
|
|
2021
Q3 | $211K | Sell |
789
-61
| -7% | -$16K | 0.01% | 833 |
|
|
2021
Q2 | $213K | Sell |
850
-5
| -0.6% | -$1.26K | 0.01% | 814 |
|
|
2021
Q1 | $220K | Buy |
855
+32
| +4% | +$6.92K | 0.01% | 926 |
|
|
2020
Q4 | $191K | Buy |
823
+56
| +7% | +$10K | 0.01% | 840 |
|
|
2020
Q3 | $112K | Hold |
767
| – | – | 0.01% | 899 |
|
|
2020
Q2 | $112K | Buy |
767
+240
| +46% | +$30.8K | 0.01% | 867 |
|
|
2020
Q1 | $54K | Hold |
527
| – | – | ﹤0.01% | 1079 |
|
|
2019
Q4 | $87K | Sell |
527
-90
| -15% | -$13.9K | ﹤0.01% | 998 |
|
|
2019
Q3 | $91K | Sell |
617
-72
| -10% | -$10.1K | 0.01% | 927 |
|
|
2019
Q2 | $100K | Sell |
689
-7
| -1% | -$1.01K | 0.01% | 907 |
|
|
2019
Q1 | $89K | Sell |
696
-37
| -5% | -$4.59K | 0.01% | 900 |
|
|
2018
Q4 | $75K | Sell |
733
-13
| -2% | -$1.63K | 0.01% | 929 |
|
|
2018
Q3 | $110K | Buy |
746
+77
| +12% | +$11K | 0.01% | 850 |
|
|
2018
Q2 | $93K | Buy |
669
+1
| +0.1% | +$142 | 0.01% | 815 |
|
|
2018
Q1 | $98K | Sell |
668
-400
| -37% | -$65.3K | 0.01% | 759 |
|
|
2017
Q4 | $181K | Buy |
1,068
+13
| +1% | +$2.08K | 0.02% | 569 |
|
|
2017
Q3 | $156K | Hold |
1,055
| – | – | 0.02% | 583 |
|
|
2017
Q2 | $134K | Sell |
1,055
-46
| -4% | -$5.84K | 0.01% | 603 |
|
|
2017
Q1 | $142K | Buy |
1,101
+496
| +82% | +$61.4K | 0.01% | 562 |
|
|
2016
Q4 | $67K | Hold |
605
| – | – | 0.01% | 729 |
|
|
2016
Q3 | $60K | Buy |
605
+16
| +3% | +$1.55K | 0.01% | 747 |
|
|
2016
Q2 | $52K | Buy |
589
+11
| +2% | +$1.06K | 0.01% | 794 |
|
|
2016
Q1 | $54K | Buy |
+578
| New | +$51.8K | 0.01% | 769 |
|
Other funds holding AMP
VCM
VPM
N
Geneos Wealth Management's AMP Position: Q1 2026 in Review
Geneos Wealth Management held its Ameriprise Financial (AMP) position steady in Q1 2026 at 117 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.
Geneos Wealth Management first reported a position in AMP in Q1 2016 and has held it in 41 quarters since. The position peaked at $548K in Q1 2025. 1,383 funds tracked by Wall St. Rank hold AMP as of Q1 2026.
- Geneos Wealth Management held 117 shares of Ameriprise Financial worth $52K as of Q1 2026.
- Geneos Wealth Management left its Ameriprise Financial share count unchanged in Q1 2026.
- Ameriprise Financial made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1414 holding.
- Geneos Wealth Management first reported a position in Ameriprise Financial in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Ameriprise Financial position peaked at $548K in Q1 2025.
- 1,383 funds tracked by Wall St. Rank held Ameriprise Financial as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.